Brief: Amphastar Pharmaceuticals Reports Financial Results For The Three Months And Full-Year Ended December 31, 2020

Amphastar Pharmaceuticals,

15/03/2021 20:42

March 15 (Reuters) - Amphastar Pharmaceuticals Inc  AMPH.O :
    * AMPHASTAR PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR
THE
THREE MONTHS AND FULL-YEAR ENDED DECEMBER 31, 2020
    * Q4 GAAP LOSS PER SHARE $0.13
    * Q4 REVENUE $95.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$88.9
MILLION
    * Q4 ADJUSTED NON-GAAP EARNINGS PER SHARE $0.16
    * Q4 EARNINGS PER SHARE ESTIMATE $0.14 -- REFINITIV IBES
DATA

Source text for Eikon:  ID:nGNXbn2tmN 
Further company coverage:  AMPH.O 

 ((Reuters.Briefs@thomsonreuters.com;))